Product Code: ETC7550828 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pharmaceutical market import shipment demonstrated a steady expansion with a CAGR of 5.4% from 2020 to 2024. The growth rate accelerated between 2023 and 2024, showing increased momentum. Overall, the market exhibited consistent growth over the period, indicating positive trends in the pharmaceutical import sector.
The India Pharmaceutical Market is one of the largest in the world, driven by factors such as a growing population, increasing healthcare awareness, and rising disposable incomes. The market is highly competitive, with both domestic and multinational companies vying for market share. Generics dominate the market due to their affordability, accounting for a significant portion of pharmaceutical sales. The government`s focus on promoting generic drugs through initiatives like Jan Aushadhi and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has further boosted the penetration of generic drugs in the country. Additionally, the increasing prevalence of chronic diseases, a rapidly expanding middle-class population, and a strong emphasis on research and development are expected to drive further growth in the India Pharmaceutical Market.
The India Pharmaceutical Market is experiencing significant growth driven by increasing healthcare needs and a growing middle-class population. Key trends include a shift towards specialty medicines, rising demand for generic drugs, and a focus on research and development for innovative treatments. Opportunities lie in expanding access to healthcare in rural areas, developing affordable and high-quality generic drugs for both domestic and international markets, and leveraging technology for improved healthcare delivery. With a supportive regulatory environment and a skilled workforce, the Indian pharmaceutical industry is poised for further expansion and collaborations with global partners to drive innovation and address emerging healthcare challenges.
The India Pharmaceutical Market faces several challenges including intense competition, price control regulations, complex regulatory environment, counterfeit drugs, and inadequate healthcare infrastructure in rural areas. The market is highly fragmented with numerous players vying for market share, leading to pricing pressures and the need for continuous innovation to stay competitive. Price control regulations imposed by the government can impact profit margins for pharmaceutical companies. The regulatory landscape in India is often unpredictable and can create delays in obtaining approvals for new drugs. The presence of counterfeit drugs in the market poses a significant threat to public health and undermines the reputation of genuine pharmaceutical products. Additionally, the lack of adequate healthcare infrastructure in rural areas presents distribution challenges for pharmaceutical companies looking to reach underserved populations.
The India Pharmaceutical Market is primarily driven by factors such as a growing population with increasing healthcare needs, rising income levels leading to greater affordability of healthcare services, expanding health insurance coverage, and a shift towards lifestyle diseases requiring long-term medication. Additionally, the government`s initiatives to improve healthcare infrastructure, promote generic drug usage through various schemes, and encourage research and development in the pharmaceutical sector are also significant drivers. The increasing prevalence of chronic diseases, such as diabetes and cardiovascular disorders, further boosts the demand for pharmaceutical products in India. Overall, the market is driven by a combination of demographic trends, economic factors, government policies, and changing disease patterns shaping the healthcare landscape in the country.
The Indian pharmaceutical market is heavily regulated by the government to ensure safety, affordability, and accessibility of medications. The government has implemented various policies such as the Drug Price Control Order (DPCO) to cap prices of essential medicines, the National Pharmaceutical Pricing Authority (NPPA) to monitor and regulate drug prices, and the New Drug Policy to promote research and development in the pharmaceutical sector. Additionally, the government has introduced initiatives like the Make in India campaign to encourage domestic manufacturing of pharmaceuticals and reduce dependency on imports. These policies aim to balance the needs of the industry with public health priorities, making India one of the largest pharmaceutical markets globally.
The India Pharmaceutical Market is poised for significant growth in the coming years, driven by factors such as increasing healthcare expenditure, a growing population, rising awareness and demand for healthcare services, and a supportive regulatory environment. The market is expected to expand due to the focus on research and development, innovation in drug manufacturing processes, and the increasing prevalence of chronic diseases. Additionally, the shift towards generic drugs and biosimilars, along with the rising adoption of digital health technologies, will further propel the market forward. However, challenges such as pricing pressures, regulatory changes, and competition from domestic and international players will require companies to adapt and innovate to maintain their competitive edge in this dynamic and rapidly evolving market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pharmaceutical Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 India Pharmaceutical Market - Industry Life Cycle |
3.4 India Pharmaceutical Market - Porter's Five Forces |
3.5 India Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2021 & 2031F |
3.6 India Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 India Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 India Pharmaceutical Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 India Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.10 India Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare expenditure in India |
4.2.2 Rising prevalence of chronic diseases |
4.2.3 Government initiatives to promote generic drug usage |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment |
4.3.2 Pricing pressures from government regulations |
4.3.3 Competition from local and international pharmaceutical companies |
5 India Pharmaceutical Market Trends |
6 India Pharmaceutical Market, By Types |
6.1 India Pharmaceutical Market, By Prescription Type |
6.1.1 Overview and Analysis |
6.1.2 India Pharmaceutical Market Revenues & Volume, By Prescription Type, 2021- 2031F |
6.1.3 India Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 India Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2021- 2031F |
6.2 India Pharmaceutical Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 India Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2021- 2031F |
6.2.3 India Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2021- 2031F |
6.2.4 India Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2021- 2031F |
6.3 India Pharmaceutical Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 India Pharmaceutical Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.3.3 India Pharmaceutical Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3.4 India Pharmaceutical Market Revenues & Volume, By Biosimilars, 2021- 2031F |
6.4 India Pharmaceutical Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 India Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.4.3 India Pharmaceutical Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.4 India Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.4.5 India Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.4.6 India Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.7 India Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2021- 2031F |
6.5 India Pharmaceutical Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 India Pharmaceutical Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.3 India Pharmaceutical Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 India Pharmaceutical Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5.5 India Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2021- 2031F |
6.5.6 India Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.6.3 India Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 India Pharmaceutical Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.5 India Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Pharmaceutical Market Import-Export Trade Statistics |
7.1 India Pharmaceutical Market Export to Major Countries |
7.2 India Pharmaceutical Market Imports from Major Countries |
8 India Pharmaceutical Market Key Performance Indicators |
8.1 Number of new drug approvals in India |
8.2 Investment in research and development by pharmaceutical companies |
8.3 Adoption rate of digital health technologies in the pharmaceutical sector |
9 India Pharmaceutical Market - Opportunity Assessment |
9.1 India Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2021 & 2031F |
9.2 India Pharmaceutical Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 India Pharmaceutical Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 India Pharmaceutical Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.5 India Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.6 India Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Pharmaceutical Market - Competitive Landscape |
10.1 India Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 India Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |